Product Details for NDA 019001
BEPADIN (BEPRIDIL HYDROCHLORIDE)
200MG
Marketing Status: Discontinued
300MG
Marketing Status: Discontinued
400MG
Marketing Status: Discontinued
200MG
Marketing Status: Discontinued
Active Ingredient: BEPRIDIL HYDROCHLORIDE
Proprietary Name: BEPADIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019001
Product Number: 001
Approval Date: Dec 28, 1990
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
BEPADIN (BEPRIDIL HYDROCHLORIDE)
Proprietary Name: BEPADIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019001
Product Number: 001
Approval Date: Dec 28, 1990
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
300MG
Marketing Status: Discontinued
Active Ingredient: BEPRIDIL HYDROCHLORIDE
Proprietary Name: BEPADIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019001
Product Number: 002
Approval Date: Dec 28, 1990
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
BEPADIN (BEPRIDIL HYDROCHLORIDE)
Proprietary Name: BEPADIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019001
Product Number: 002
Approval Date: Dec 28, 1990
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
400MG
Marketing Status: Discontinued
Active Ingredient: BEPRIDIL HYDROCHLORIDE
Proprietary Name: BEPADIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019001
Product Number: 003
Approval Date: Dec 28, 1990
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: BEPADIN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N019001
Product Number: 003
Approval Date: Dec 28, 1990
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status: Discontinued
Patent and Exclusivity Information